Alliance A021804: A prospective, multi-institutional phase II trial evaluating temozolomide versus temozolomide and olaparib for advanced pheochromocytoma and paraganglioma

Authors

Maged Khalil MD, Lehigh Valley Health NetworkFollow

Publication/Presentation Date

5-2023

Published In/Presented At

Jaydira Del Rivero et al.,

Alliance A021804: A prospective, multi-institutional phase II trial evaluating temozolomide versus temozolomide and olaparib for advanced pheochromocytoma and paraganglioma.. JCO 41, TPS4191-TPS4191(2023).

Disciplines

Medicine and Health Sciences

Department(s)

Department of Medicine, Lehigh Valley Topper Cancer Institute

Document Type

Article